These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 6616780)
1. Ventricular fibrillation in a conscious canine preparation of sudden coronary death--prevention by short- and long-term amiodarone administration. Patterson E; Eller BT; Abrams GD; Vasiliades J; Lucchesi BR Circulation; 1983 Oct; 68(4):857-64. PubMed ID: 6616780 [No Abstract] [Full Text] [Related]
2. [Effect of previous administration of amiodarone on the early incidence of ventricular fibrillation during experimental myocardial ischemia]. Spadaro J; Hashimoto LM; Franco RS; Bregagnollo EA; Tucci PJ Arq Bras Cardiol; 1984 Jan; 42(1):25-9. PubMed ID: 6743037 [No Abstract] [Full Text] [Related]
3. Prevention of ventricular fibrillation by bretylium in a conscious canine model of sudden coronary death. Holland K; Patterson E; Lucchesi BR Am Heart J; 1983 May; 105(5):711-7. PubMed ID: 6846113 [TBL] [Abstract][Full Text] [Related]
4. [Effect of amiodarone on stimulatory convertibility and degeneration into ventricular fibrillation of induced ventricular tachycardias in the pig]. Hottinger S; Mettler D; Leupi F; Gertsch M Schweiz Med Wochenschr; 1985 Nov; 115(45):1594-6. PubMed ID: 4081686 [TBL] [Abstract][Full Text] [Related]
5. Left stellectomy in the prevention of ventricular fibrillation caused by acute myocardial ischemia in conscious dogs with anterior myocardial infarction. Schwartz PJ; Stone HL Circulation; 1980 Dec; 62(6):1256-65. PubMed ID: 7438361 [TBL] [Abstract][Full Text] [Related]
6. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357 [TBL] [Abstract][Full Text] [Related]
7. [Effect of cordaron on the threshold of ventricular fibrillation in cats]. Stoliarchuk AA; Storozhuk BG Kardiologiia; 1982 Nov; 22(11):82-4. PubMed ID: 7154512 [TBL] [Abstract][Full Text] [Related]
8. Relation of serum reverse T3 to amiodarone antiarrhythmic efficacy and toxicity. Kerin NZ; Blevins RD; Benaderet D; Faitel K; Jarandilla R; Garfinkel C; Klein S; Rubenfire M Am J Cardiol; 1986 Jan; 57(1):128-30. PubMed ID: 3942055 [TBL] [Abstract][Full Text] [Related]
9. Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death. Kitzen JM; Lynch JJ; Uprichard AC; Venkatesh N; Lucchesi BR Pharmacology; 1988; 37(3):171-86. PubMed ID: 3227051 [TBL] [Abstract][Full Text] [Related]
10. Prevention of sudden coronary death by chronic antiarrhythmic therapy. Koch-Weser J Adv Cardiol; 1978; 25():206-28. PubMed ID: 360790 [No Abstract] [Full Text] [Related]
11. Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. Lubbe WF; McFadyen ML; Muller CA; Worthington M; Opie LH Am J Cardiol; 1979 Mar; 43(3):533-40. PubMed ID: 217261 [TBL] [Abstract][Full Text] [Related]
12. Interaction of platelets with the vessel wall in the pathophysiology of sudden cardiac death. Hammon JW; Oates JA Circulation; 1986 Feb; 73(2):224-6. PubMed ID: 3510761 [TBL] [Abstract][Full Text] [Related]
13. Prognosis after sudden cardiac death without associated myocardial infarction: one year follow-up of empiric therapy with amiodarone. Peter T; Hamer A; Weiss D; Mandel WJ Am Heart J; 1984 Feb; 107(2):209-13. PubMed ID: 6695654 [TBL] [Abstract][Full Text] [Related]
14. Cardiac arrest and sudden death in patients treated with amiodarone for sustained ventricular tachycardia or ventricular fibrillation: risk stratification based on clinical variables. DiCarlo LA; Morady F; Sauve MJ; Malone P; Davis JC; Evans-Bell T; Winston SA; Scheinman MM Am J Cardiol; 1985 Feb; 55(4):372-4. PubMed ID: 3969871 [TBL] [Abstract][Full Text] [Related]
15. Value of Holter monitoring in identifying risk for sustained ventricular arrhythmia recurrence on amiodarone. Marchlinski FE; Buxton AE; Flores BT; Doherty JU; Waxman HL; Josephson ME Am J Cardiol; 1985 Mar; 55(6):709-12. PubMed ID: 3976513 [TBL] [Abstract][Full Text] [Related]
16. Long-term clinical outcome of ventricular tachycardia or fibrillation treated with amiodarone. McGovern B; Garan H; Malacoff RF; DiMarco JP; Grant G; Sellers TD; Ruskin JN Am J Cardiol; 1984 Jun; 53(11):1558-63. PubMed ID: 6731300 [TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study. Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH; Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672 [TBL] [Abstract][Full Text] [Related]
18. Usefulness of electrophysiologic testing in evaluation of amiodarone therapy for sustained ventricular tachyarrhythmias associated with coronary heart disease. Horowitz LN; Greenspan AM; Spielman SR; Webb CR; Morganroth J; Rotmensch H; Sokoloff NM; Rae AP; Segal BL; Kay HR Am J Cardiol; 1985 Feb; 55(4):367-71. PubMed ID: 3969870 [TBL] [Abstract][Full Text] [Related]
19. Comparison of cardiac electrophysiologic effects of experimental hypothyroidism and chronic oral amiodarone administration in dogs. Liu PM; Zhang XM; Wu W; Li JM; Tang Y Chin Med J (Engl); 1994 May; 107(5):375-9. PubMed ID: 7924581 [TBL] [Abstract][Full Text] [Related]
20. Intravenous amiodarone in ventricular fibrillation. Chapman JR; Boyd MJ Br Med J (Clin Res Ed); 1981 Mar; 282(6268):951-2. PubMed ID: 6781670 [No Abstract] [Full Text] [Related] [Next] [New Search]